% | $
Quotes you view appear here for quick access.

OncoGenex Pharmaceuticals, Inc. Message Board

  • bagholderzunite bagholderzunite Apr 17, 2014 8:46 AM Flag

    ASCO late breaker theory

    I think I'm close to conceding that this theory was off the mark

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • OXGI probably submitted a really really late breaking abstract to ASCO. Perhaps, they should consider submitting an abstract on trial design, and that may be accepted next year.

      On the bright side, there are plenty of other ASCO abstracts that were accepted. Perhaps, check out for cancer treatments with local and systemic effects. Go visit a booth or 5.

    • Any companies announce ASCO late breaking abstracts accepted yet? Big bump in stock today. Still mid-April.

    • It does seem that way.

      Though I wouldn't necessarily view that in a bad light (i.e. it's bad data and they're searching for anything positive). Scott mentioned in the Credit Suisse Healthcare conference in Novemeber that the timeline would likely be 2-3 months from data lock, but that they wanted to be as conservative as possible in evaluating the data (i.e. last thing they wanted was to announce results to the public that ended up being incorrect).

      As someone mentioned, don't think Scott and Co. would rush to announce data just for the sake of meeting a conference deadline. Given the current situation, I'd guess that we'll hear something in the next 2-3 weeks, and a potential presentation at a later conference.

0.95-0.02(-2.06%)2:18 PMEDT